Herjan Coelingh Bennink

Pantarhei Bioscience BV is a bio-pharmaceutical company located in Zeist, Netherlands, that develops new treatments for women's health and reproductive endocrine oncology. Pantarhei's objective is to discover and develop safe and effective new treatments for women's health and reproductive endocrine oncology using existing targets, hormones, biologicals, and drugs. The Dutch company has extensive experience in the clinical development and creation of new drugs. Pantarhei develops patent-protected treatments up to phase II efficacy and safety, and after generating favorable human proof-of-concept efficacy and safety data, projects are sold or licensed-out to a (pharmaceutical) partner for final development (phase III), regulatory approval, and commercialization. The private company was founded in 2000 by Herjan Coelingh Bennink, and Yvette Zimmerman has been the CEO since 2007.

Organon Biosciences NV specializes in biopharmaceutical manufacturing and distribution services. It develops products in the areas of cardiovascular disease, fertility, gynecology, anesthesia, respiratory, consumer health care, and neuroscience, immunology, animal health, and oncology. The company’s products include mometasone furoate inhalation powder, moxifloxacin, pegylated liposomal doxorubicin HCI, desogestrel, desloratadine, sun care, cold/flu medicine, foot care, follitropin beta, formoterol fumarate inhalation powder, hormone therapy, and canine vaccines. It was founded in 1923 and is headquartered in Oss, the Netherlands.

Delphi Bioscience BV develops health screening solutions for vaginal and cervical infections. It offers Delphi Screener, a self-sampling device which can be used by women or doctors, to collect reliable cervico-vaginal samples without the need for inserting a speculum during a pelvic exam. The company was founded in 2006 and is headquartered in Scherpenzeel, the Netherlands.